Intensified intensity-modulated radiotherapy in anal cancer with prevalent HPV p16 positivity

Table 6 Comparison with outcome data reported in the literature

	Bazan et al[24]	Chuong et al[29]	Dasgupta et al[31]	Koerber et al[30]	Mitchell et al[32]	Pepek et al[26]	Janssen et al[23]	Tozzi et al[22]	Current study
No. pz	29 pz	52 pz	45 pz	68 pz	65 pz	47 pz	25 pz	36 pz	41 pz
LC	92%2	91.3%2	87%1	75.3%2	90%1	90%1	92%1	78.1%3	92%1
OS	88%2	91.1%2	93%1	82.9%2	96%1	85%1	88%1		93%1

¹Two years;

²Three years;

³Five years. LC: Local control; OS: Overall survival.